Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

BioNTech SE

BNTX•NASDAQ
Healthcare
Biotechnology
$109.37
$-1.05(-0.95%)
U.S. Market is Open • 12:27

BioNTech SE (BNTX) Stock Overview

Explore BioNTech SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap26.5B
P/E Ratio-39.17
EPS (TTM)$-2.84
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$73.93
3 Months$91.93
1 Year Target$77.65

BNTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioNTech SE (BNTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.52, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $77.65.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -39.17 and a market capitalization of 26.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.25%
5-Day Change
3.54%
1-Month Change
4.34%
3-Month Change
13.59%
6-Month Change
-1.04%
Year-to-Date (YTD) Change
13.92%
1-Year Change
-6.56%
3-Year Change
-19.91%
5-Year Change
-3.89%
All-Time (Max) Change
673.49%

Contact Information

https://www.biontech.de
49 6131 9084 0
An der Goldgrube 12, Mainz, NaN, 55131

Company Facts

67,720 Employees
IPO DateOct 10, 2019
CountryDE
Actively Trading

Frequently Asked Questions